Corrigendum to: Fibulin-4 as a potential extracellular vesicle marker of fibrosis in patients with cirrhosis https://doi.org/10.1002/2211-5463.13842

IF 2.8 4区生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY

FEBS Open Bio Pub Date : 2024-08-22 DOI:10.1002/2211-5463.13885

引用次数: 0

Abstract

The author affiliations of the paper by Terai et al. [1] contains a typographical error:

2. Future Medical Research Center for Exosome and Designer Cells (F-DEC), Niigata University Japan

The correct affiliation acronym is shown below:

2. Future Medical Research Center for Exosome and Designer Cells (F-EDC), Niigata University Japan

查看原文本刊更多论文

更正：纤维蛋白-4 作为肝硬化患者纤维化的潜在细胞外囊泡标记物 https://doi.org/10.1002/2211-5463.13842。

Terai 等人的论文[1]中的作者单位有一处排印错误：2.日本新泻大学外泌体与设计者细胞未来医学研究中心（F-DEC）正确的作者单位缩写如下：2.日本新泻大学外泌体和设计者细胞未来医学研究中心 (F-EDC)

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

FEBS Open Bio BIOCHEMISTRY & MOLECULAR BIOLOGY-

CiteScore

5.10

自引率

0.00%

发文量

173

审稿时长

10 weeks

期刊介绍： FEBS Open Bio is an online-only open access journal for the rapid publication of research articles in molecular and cellular life sciences in both health and disease. The journal''s peer review process focuses on the technical soundness of papers, leaving the assessment of their impact and importance to the scientific community. FEBS Open Bio is owned by the Federation of European Biochemical Societies (FEBS), a not-for-profit organization, and is published on behalf of FEBS by FEBS Press and Wiley. Any income from the journal will be used to support scientists through fellowships, courses, travel grants, prizes and other FEBS initiatives.